“By offering wound care specialty access through AristaMD’s platform, we aim to improve patient quality of life, time efficiency, overall patient care and reduce patient expenses that would come from a visit to a costly wound care clinic,” Brooke LeVasseur, CEO of AristaMD.
SAN DIEGO and SAVANNAH, Ga. (PRWEB) May 15, 2019
AristaMD, an innovative telehealth platform that delivers timely, documented access to specialist insight through eConsults, partners with Corstrata, a provider of digital healthcare IT solutions and services for wound prevention and care management, to add board-certified wound and ostomy specialists to its already extensive specialist panel. Due to high client demand, AristaMD’s initiative to partner with Corstrata will ensure its eConsult platform continues to offer the most comprehensive access to specialty care. AristaMD’s wound and ostomy panel is set to launch May 14th.
“It is estimated that there are approximately 6.5 million patients in the United State that currently receive wound treatment, costing around $25 billion annually in acute and chronic wound care management,” said Brooke LeVasseur, CEO of AristaMD. “By offering wound care specialty access through AristaMD’s platform, we aim to improve patient quality of life, time efficiency, overall patient care and reduce patient expenses that would come from a visit to a costly wound care clinic.”
AristaMD-enrolled clinicians can request a consultation by submitting a general consultative service query. If the platform identifies a query related to wound or ostomy and the physician is able to provide an image the consultation request is assigned and added to the queue of scheduled wound/ostomy panelists. The assigned panelist will then determine if the patient can be managed at the PCP level or needs to schedule a face-to-face specialist visit.
“With a growing wound population and the highly specialized nature of wound care, access to
board certified wound and ostomy specialists that can accurately identify wound types and associated staging, and recommend the most appropriate wound treatment and dressings, are critical to ensuring the best possible outcomes for wound patients,” added Katherine Piette, CEO and Co-Founder, Corstrata. “We are thrilled to partner with AristaMD to enable their clinicians with access to our experienced team of wound and ostomy experts to provide evidence based, best practice wound treatments to improve patient outcomes.”
AristaMD enables primary care providers and patients to engage in virtual collaborations with a national panel of top specialists. By expanding its panel of specialists, AristaMD is able to provide excellent, rapid care for patients, who usually wait weeks to months to see a wound or ostomy specialist.
For additional information on AristaMD, please visit http://www.aristamd.com.
eConsult Solutions That Improve Quality of Care
AristaMD is focused on improving patient outcomes through more timely access to specialty care. Its eConsult platform provides a telehealth solution that empowers primary care providers with clinical workup checklists and the ability to conduct electronic consults (also known as eConsults or virtual consults) to significantly improve the patient referral process and allow greater access to timely, high-quality care. Designed to seamlessly integrate into physician referral workflows, the platform allows payers and providers to quickly and cost-effectively launch specialist eConsults using their own specialists or those provided by AristaMD’s board-certified panel of experts. AristaMD's platform has proven to deliver cost-effective, timely access to specialty care through eConsults, significantly reducing the need for face-to-face visits while increasing patient satisfaction. Committed to driving better health outcomes, AristaMD partners with healthcare stakeholders to ensure their success in the transition to value-based care.
Corstrata was founded by two passionate healthcare experts, Katherine Piette and Joseph Ebberwein, with the goal of improving access to technology-enabled, evidence-based care for patients with chronic wounds, which currently costs the U.S. $33B annually. Home health agencies, hospices, rehab hospitals, skilled nursing facilities, wound care and ostomy related manufacturers, self-funded employers, clinically integrated networks, and third-party payers (Medicare Advantage, Medicaid MCOs) benefit from Corstrata’s unique combination of clinical expertise, digital technologies and telemedicine to provide expert recommendations to improve care for wound patients. The company delivers a Comprehensive Wound Care Management Program, Wound Patient Consultations, and specific services such as wound program assessment, formulary design, treatment guidelines assessment, wound documentation review, and education. Wound program development is available for Pressure Injury (Ulcer) Prevention and Management, Diabetic Foot Ulcer Prevention and Management, Ostomy Care and Management, and Palliative Wound Management. For more information about Corstrata, visit http://www.corstrata.com.